Literature DB >> 19272799

Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.

Enver Ozgür1, Axel Heidenreich, Oguzhan Dagtekin, Udo Engelmann, Wilhelm Bloch.   

Abstract

OBJECTIVE: Ephrin (Eph) receptors are receptor tyrosine kinases; both EphrinB2, as a ligand, and EphB4, as a receptor, are involved in angiogenesis. EphrinB2 is expressed on arteries and EphB4, a specific receptor for EphrinB2, is expressed on veins. It is unknown whether involvement of arteries and veins in tumor angiogenesis is distinctive. Here we investigated their distribution in normal and malignant tissue of the urogenital tract.
MATERIALS AND METHODS: Five-micrometer-thick paraffin sections from nontumoral and tumoral tissues of kidney (n = 12), bladder (n = 33), and prostate (n = 20) were immunoreacted with antisera against EphB4 and EphrinB2 using the avidin-biotin-peroxidase complex technique. Comparisons of EphB4 and EphrinB2 stained arterial and venous vessels in the nontumoral and tumoral sections were evaluated in a semiquantitative analysis as frequency of the vessels in a predetermined tumor area counted under light microscopy.
RESULTS: Expression of EphrinB2 in arterial and EphB4 in venous endothelium was significantly greater in tumoral sections compared with nontumoral sections. No statistically significant correlation in comparing the labeling patterns for EphrinB2 with the labeling patterns for EphB4 was observed in nontumoral as well as tumoral sections.
CONCLUSIONS: The high expression of EphrinB2 in arterial and EphB4 in venous endothelium of urogenital tract tumors might contribute to their involvement in the progression of tumor angiogenesis. The relation between arteries and veins in the normal and tumor tissues is unchanged.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272799     DOI: 10.1016/j.urolonc.2008.12.020

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  10 in total

1.  Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.

Authors:  Benjamin D Ferguson; Maria S Tretiakova; Mark W Lingen; Parkash S Gill; Ravi Salgia
Journal:  Growth Factors       Date:  2014-11-13       Impact factor: 2.511

Review 2.  Eph/ephrin signaling in the kidney and lower urinary tract.

Authors:  Anna-Carina Weiss; Andreas Kispert
Journal:  Pediatr Nephrol       Date:  2015-04-23       Impact factor: 3.714

3.  Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.

Authors:  Yanyang Tu; Shiming He; Jianfang Fu; Gang Li; Ruxiang Xu; Hongliu Lu; Jianping Deng
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

4.  Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors.

Authors:  Jian You; Rui Zhang; Chiyi Xiong; Meng Zhong; Maritess Melancon; Sanjay Gupta; Alpa M Nick; Anil K Sood; Chun Li
Journal:  Cancer Res       Date:  2012-08-03       Impact factor: 12.701

5.  Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions.

Authors:  Hiroki Saito; Mariko Oikawa; Atsumu Kouketsu; Tetsu Takahashi; Hiroyuki Kumamoto
Journal:  Odontology       Date:  2019-10-25       Impact factor: 2.634

6.  Identification of HSC/MPP expansion units in fetal liver by single-cell spatiotemporal transcriptomics.

Authors:  Suwei Gao; Qiang Shi; Yifan Zhang; Guixian Liang; Zhixin Kang; Baofeng Huang; Dongyuan Ma; Lu Wang; Jianwei Jiao; Xiangdong Fang; Cheng-Ran Xu; Longqi Liu; Xun Xu; Berthold Göttgens; Cheng Li; Feng Liu
Journal:  Cell Res       Date:  2021-08-02       Impact factor: 25.617

7.  EphrinB2 expression in prostate adenocarcinoma: Implications for targeted therapy.

Authors:  Chhavi Gupta; Akash Sali; Binyun Ma; Alexandra Jackovich; Sarmad Sadeghi; David Quinn; Parkash Gill; Inderbir Gill
Journal:  Pathol Res Pract       Date:  2020-04-19       Impact factor: 3.309

8.  Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.

Authors:  Ling-Dan Dong; Xiang-Lin Cheng; Long Zhou; Qing Huang; Jun-Chuan Li; Cun-Jian Yi
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

9.  High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer.

Authors:  Wen-Jing Yue; Yi-Pin Liu; Ming Li; Cheng-Xia Liu; Shao-Jia Mou; Qian-Kun Li; Zi-Ping Chen
Journal:  Oncol Lett       Date:  2018-07-24       Impact factor: 2.967

10.  Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.

Authors:  María Victoria Mencucci; Lara Lapyckyj; Marina Rosso; María José Besso; Denise Belgorosky; Mariana Isola; Silvia Vanzulli; Catalina Lodillinsky; Ana María Eiján; Juan Carlos Tejerizo; Matías Ignacio Gonzalez; María Ercilia Zubieta; Mónica Hebe Vazquez-Levin
Journal:  Front Oncol       Date:  2020-03-27       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.